1. Home
  2. AVDL vs GRDN Comparison

AVDL vs GRDN Comparison

Compare AVDL & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.69

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Guardian Pharmacy Services Inc.

GRDN

Guardian Pharmacy Services Inc.

HOLD

Current Price

$33.88

Market Cap

1.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVDL
GRDN
Founded
2015
2004
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail-Drug Stores and Proprietary Stores
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
1996
2024

Fundamental Metrics

Financial Performance
Metric
AVDL
GRDN
Price
$21.69
$33.88
Analyst Decision
Buy
Strong Buy
Analyst Count
8
3
Target Price
$19.14
$33.33
AVG Volume (30 Days)
1.6M
270.4K
Earning Date
03-02-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.28
Revenue
$248,517,000.00
$1,389,638,000.00
Revenue This Year
$65.47
$19.50
Revenue Next Year
$30.88
$0.48
P/E Ratio
N/A
$117.91
Revenue Growth
79.88
18.68
52 Week Low
$6.38
$17.78
52 Week High
$23.57
$37.43

Technical Indicators

Market Signals
Indicator
AVDL
GRDN
Relative Strength Index (RSI) 63.88 62.23
Support Level $21.52 $30.85
Resistance Level $21.69 $33.00
Average True Range (ATR) 0.06 1.43
MACD -0.01 0.32
Stochastic Oscillator 66.67 98.07

Price Performance

Historical Comparison
AVDL
GRDN

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About GRDN Guardian Pharmacy Services Inc.

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.

Share on Social Networks: